Release Date: 12/12/18 11:19 Summary: Bombora growth expands open pit potential Price Sensitive: Yes Download Document 8.8MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%